Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
Why CRMs Fail Pharma, and How Tech-Led Marketing Reclaims ROI
The Broken Promise of CRM in Pharma MarketingFor years, CRM in pharma marketing was sold as the silver bullet. Buy the system, train the reps, and suddenly you’d have airtight engagement with doctors…
|
Why Your Omnichannel Marketing Is Just Noise, And How to Fix It
We analyzed 20 pharma websites and spoke with 10 CMOs and digital leads from mid-to-large pharma brands across India. Almost everyone said the same thing. "We're spending on omnichannel HCP…
|
Fixing MLR Bottlenecks: How Smart Tech Turns Compliance Into Growth
Ask any pharma CMO what slows marketing down, and the answer comes fast: MLR reviews. The Medical, Legal, and Regulatory process that’s supposed to keep pharma safe is also what keeps campaigns…
|
What CMOs Need from Their Next Agency (Hint: It’s Not Creative)
The myth of “big ideas”: Every CMO has heard it. Agencies pitch themselves as the home of big creative ideas. Bold campaigns. Stunning visuals. Award-winning decks. But here’s the uncomfortable truth…
